Aurinia Pharmaceuticals (AUPH) has swung into profitability over the past year, with earnings climbing at an impressive 43.8% per year on average for the past five years. Investors have watched as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback